The CA 15-3 test is a blood test used primarily to monitor patients with breast cancer. CA 15-3 stands for Cancer Antigen 15-3, a protein often found at higher levels in individuals with certain types of cancer, particularly breast carcinoma. While it is not used for screening or diagnosis in healthy individuals, it is valuable in tracking treatment response, detecting recurrence, and assessing disease progression. Elevated CA 15-3 levels may correlate with tumor burden. Factors like liver disease, benign breast conditions, and other cancers can also raise levels. Interpretation should always consider clinical context alongside imaging and other tests.Reports On : With 12 HoursSample Type : BloodFasting : Not Required Click Here To Book A Test

The CA-125 test measures the level of cancer antigen 125, a protein found in the blood, often elevated in ovarian cancer and certain other conditions. It is primarily used to monitor treatment response, detect recurrence in women with known ovarian cancer, and sometimes assist in evaluating pelvic masses. Elevated CA-125 levels may also occur in non-cancerous conditions like endometriosis, menstruation, pregnancy, liver disease, and pelvic inflammatory disease, so results are interpreted alongside imaging and clinical findings. This test is not recommended for routine screening in asymptomatic women due to limited specificity.Reports On : With 12 HourSample Type : BloodFasting : Not Required Click Here To Book A Test

The BUN (Blood Urea Nitrogen) test measures the amount of urea nitrogen in the blood, which is a waste product formed in the liver when protein is metabolized. Urea is normally excreted by the kidneys, so this test provides important information about kidney function and overall metabolic health. Elevated BUN levels may indicate kidney disease, dehydration, high-protein diet, or heart failure, while low levels can occur in malnutrition, liver disease, or overhydration. It is commonly ordered alongside creatinine to assess renal function, guide treatment, and monitor patients with chronic conditions. Regular monitoring helps detect early kidney impairment and evaluate the effectiveness of therapies, making it a critical marker for clinicians in diagnosing and managing renal and metabolic disorders. The test…